ArticlePakistan journal of medical sciences2024

Combination of anlotinib and second-line chemotherapy as surrogate to reduce immunosuppression in patients with advanced non-small cell lung cancer.

Zhi Lou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.